Earnings Call · Q4 FY2021·2022-03-03

Q4 21EPS -14.29%·Rev n/aQ3 21EPS -3.70%·Rev n/aQ2 21EPS +24.00%·Rev n/aQ1 21EPS +53.49%·Rev n/a⚠ consensus missing

Evolus, Inc. EOLS

David Erickson — Vice President of Investor Relations

David Moatazedi — President and Chief Executive Officer

Rui Avelar — Chief Medical Officer and Head of Research

Lauren Silvernail — Chief Financial Officer and Executive Vice President, Corporate Development

+17.3%1d on move date+17.5% vs SPY3d+25.4%5d+33.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EOLS calls or request research access.

More EOLS calls Browse calls Request research access